BioXcel Therapeutics Reports Second Quarter 2023 Financial Results and Announces Strategic Reprioritization

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. PRIM
3. MU
4. DPZ
5. ACN
6. NAVN
7. DFTX
8. IBM
9. META
10. ENRD

Go back to BioXcel Therapeutics Reports Second Quarter 2023 Financial Results and Announces Strategic Reprioritization
(NASDAQ: BTAI) Delayed: 1.30 --0 (-0%)
Previous Close $1.30    52 Week High $ 
Open $1.30    52 Week Low $ 
Day High $1.30    P/E N/A 
Day Low $1.30    EPS $ 
Volume 14,141